Open Access
Med Buccale Chir Buccale
Volume 17, Number 4, Novembre 2011
Page(s) 323 - 330
Section Mises au point / Literature reviews
Published online 24 November 2011
  1. Crestani B, Schneider S, Adle-Biassette H, Debray MP, Bonay M, Aubier M. Manifestations respiratoires au cours du syndrome de Gougerot-Sjögren. Rev Mal Respir 2007;24 :535-51. [CrossRef] [PubMed] [Google Scholar]
  2. Sauvezie B, Deschaumes C, Rigal D, Baudet-Pommel M, Kemeny JL, Bonafous J, Prin P, Dubost JJ. Syndrome de Gougerot-Sjögren. Encycl Méd Chir Appareil locomoteur 14-223-A-10. Elsevier SAS, Paris, 2000. [Google Scholar]
  3. Picone O, Alby C, Frydman R, Mariette X. Syndrome de Gougerot-Sjögren en gynécologie obstétrique. Revue de la littérature. J Gynecol Obstet Biol Reprod 2006;35 :169-75. [Google Scholar]
  4. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164 : 1275-84. [CrossRef] [PubMed] [Google Scholar]
  5. Mariette X. Pathophysiology of Sjögren’s syndrome. Ann Med Intern 2003;154 :157-68. [Google Scholar]
  6. Moutsopoulos HM. Sjogren’s syndrome : autoimmune epithelitis. Clin Immunol Immunopathol 1994;72 :162-5. [CrossRef] [PubMed] [Google Scholar]
  7. Fox RI. Sjogren’s syndrome. Lancet 2005;366 :321-31. [CrossRef] [PubMed] [Google Scholar]
  8. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjogren’s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006; 54 :1165-73. [CrossRef] [PubMed] [Google Scholar]
  9. Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren’s syndrome patients. Lab Invest 2001; 81 :143-8. [CrossRef] [PubMed] [Google Scholar]
  10. Li J, Ha YM, Ku NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren’s syndrome. Lab Invest 2004; 84 :1430-8. [CrossRef] [PubMed] [Google Scholar]
  11. Fox RI. Sjogren’s syndrome : evolving therapies. Expert Opin Investig Drugs 2003;12 :247-54. [CrossRef] [PubMed] [Google Scholar]
  12. Pisella PJ, Creuzot-Garcher C, Baudouin C. Actualités sur le syndrome de Gougerot-Sjögren. J Fr Ophtalmol 1999;22 :889-92. [PubMed] [Google Scholar]
  13. Gentric-Tilly A. Syndrome de Gougerot-Sjögren du sujet âgé. Ann Med Interne 2002; 153 :378-82. [Google Scholar]
  14. Baudet-Pommel M, Deschaumes C, Sauvezie D, Sauvezie B. Syndrome de Gougerot-Sjogren : complications bucco-dentaires. Actual Odonto-Stomatol 2001;213 :65-77. [Google Scholar]
  15. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 1991;90 :701-6. [PubMed] [Google Scholar]
  16. Piette E, Reychler H. Traité de pathologies buccales et maxillo-faciales (pp. 1116-8). De Boeck Université, Bruxelles, 1991. [Google Scholar]
  17. Daniels TE. Labial salivary gland biopsy in Sjögren’s syndrome : assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27 :147-56. [CrossRef] [PubMed] [Google Scholar]
  18. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjogren’s syndrome : a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61 :554-8. [CrossRef] [PubMed] [Google Scholar]
  19. Ramos-Casals M, Loustaud-Ratti V, De Vita S , Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J. Sjogren syndrome associated with hepatitis C virus : a multicenter analysis of 137 cases. Medicine (Baltimore) 2005;84 :81-9. [CrossRef] [PubMed] [Google Scholar]
  20. Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco M, Font J. Sarcoidosis or Sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 2004;83 :85-95. [Google Scholar]
  21. Vissink A, De Jong HP,Busscher HJ, Arends J, Gravenmade EJ. Wetting properties of human saliva and saliva substitutes. J Dent Res 1986;65 :1121-4. [CrossRef] [PubMed] [Google Scholar]
  22. Marks NJ, Roberts BJ. A proposed new method for the treatment of dry mouth. Ann R Coll Surg Engl 1983;65 :191-3. [PubMed] [Google Scholar]
  23. Johansson G, Andersson G, Attstrom R, Glantz PO, Larsson K. The effect of Salinum on the symptoms of dry mouth : a pilot study. Gerodontology 1994;11 :46-9. [CrossRef] [PubMed] [Google Scholar]
  24. van der Reijden WA, van der Kwaak H, Vissink A, Veerman EC, Amerongen AV. Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjogren’s syndrome. Arthritis Rheum 1996;39 :57-63. [CrossRef] [PubMed] [Google Scholar]
  25. Vissink A, Panders AK, Nauta JM, Ligeon EE, Nikkels PG, Kallenberg CG. Applicability of saliva as a diagnostic fluid in Sjogren’s syndrome. Ann N Y Acad Sci 1993;694 :325-9. [CrossRef] [PubMed] [Google Scholar]
  26. Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T. Cor-ticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren’s syndrome. Ann Rheum Dis 1998;57 :464-9. [Google Scholar]
  27. Brennan MT, Shariff G, Lockhart PB, Fox PC. Treatment of xerostomia : a systematic review of therapeutic trials. Dent Clin North Am 2002;46 :847-56. [CrossRef] [PubMed] [Google Scholar]
  28. Takagi Y, Kimura Y, Nakamura T. Cevimeline gargle for treatment of xerostomia in patients with Sjgören’s syndrome. Ann Rheum Dis 2004;63 :749. [CrossRef] [PubMed] [Google Scholar]
  29. Ragot J-P, Auriol M, Bertrand J-C. Vieillissement des glandes salivaires : bouches sèches des personnes âgées. Actual Odonto-Stomatol 2001;215 :345-65. [Google Scholar]
  30. Strietzel FP, Martin-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, Wolff A. Electrostimulating device in the management of xerostomia. Oral Dis 2007;13 :206-13. [CrossRef] [PubMed] [Google Scholar]
  31. Iwabuchi Y, Masuhara T. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands : identification of a potential therapeutic agent for treatment of Sjorgen’s syndrome. Gen Pharmacol 1994;25 :123-9. [CrossRef] [PubMed] [Google Scholar]
  32. Mariette X. Les syndromes secs médicamenteux. Rev Rhum 2002;69 :386-9. [Google Scholar]
  33. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY. Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome : a randomized trial. Arch Intern Med 2002;162 :1293-300. [CrossRef] [PubMed] [Google Scholar]
  34. Roncin S. L’œil sec. Rev Prat 2001;31 :140-7. [Google Scholar]
  35. Hatron PY, Fauchais A. Le syndrome de Gougerot-Sjögren primitif. Rev Prat 2001;51 :159-64. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.